ethnopharmacolog
relev
eriobotrya
japonica
tradit
herbal
medicin
china
japan
long
use
treat
chronic
bronchiti
cough
aim
studi
pentacycl
triterpenoid
pt
especi
ursol
acid
ua
found
revers
competit
human
neutrophil
elastas
hne
inhibitor
howev
limit
solubl
poor
bioavail
pt
hinder
clinic
use
crude
plant
extract
may
greater
activ
isol
constitu
equival
dosag
studi
eriobotrya
japonica
loquat
leav
extract
triterpenoid
composit
loquat
leav
tcll
enrich
pt
ua
prepar
studi
aim
compar
hne
inhibitori
hnei
effect
vitro
therapeut
effect
acut
lung
injuri
ali
vivo
tcll
ua
materi
method
hnei
activ
bioassay
perform
sivelestat
sodium
hydrat
posit
control
lipopolysaccharid
lp
induc
lung
inflammatori
model
establish
evalu
tcll
therapeut
effect
ali
vivo
absorpt
ua
tcll
ua
alon
determin
use
cell
uptak
model
lcm
result
ic
valu
tcll
ua
hnei
effect
p
respect
tcll
significantli
improv
inflammatori
cell
inflammatori
cytokin
product
mice
compar
lp
group
p
addit
perform
better
ua
alon
group
p
moreov
uptak
cell
ua
tcll
higher
ua
alon
p
conclus
tcll
signific
hnei
effect
vitro
therapeut
effect
lpsinduc
inflamm
mous
model
effect
effici
ua
improv
absorpt
pt
tcll
may
one
explan
result
acut
lung
injuri
ali
syndrom
compris
acut
hypoxem
respiratori
failur
bilater
pulmonari
infiltr
mortal
rate
cure
rate
rubenfeld
et
al
lifethreaten
diseas
result
sever
infect
shock
trauma
burn
tsai
et
al
neutrophil
major
inflamm
mediat
involv
pathogenesi
variou
lung
inflammatori
diseas
includ
ali
steven
et
al
neutrophil
inflamm
attract
consider
attent
influenza
caus
influenza
sever
acut
respiratori
syndrom
virus
yokoyama
et
al
human
neutrophil
elastas
hne
kda
serin
proteas
store
azurophil
granul
neutrophil
inflamm
occur
hne
releas
neutrophil
bound
mainli
neutrophil
plasma
membran
facilit
neutrophil
migrat
inflamm
site
degrad
variou
host
protein
extracellular
matrix
protein
siedl
et
al
normal
physiolog
condit
hne
control
endogen
inhibitor
fitch
et
al
pham
rubin
william
et
al
howev
larg
amount
oxygen
radic
proteas
releas
leukocyt
recruit
inflamm
site
inactiv
endogen
inhibitor
clark
et
al
environment
factor
includ
cigarett
smoke
air
pollut
genet
factor
disrupt
proteaseantiproteas
balanc
brebner
stockley
cavarra
et
al
gooptu
loma
excess
extracellular
hne
stimul
inflammatori
lung
disord
involv
inflamm
mucu
overproduct
lung
tissu
damag
bergin
et
al
caldwel
et
al
wright
et
al
sivelestat
sodium
hydrat
clinic
regist
chemic
synthes
hne
inhibitor
approv
use
human
attenu
pulmonari
disord
improv
pulmonari
function
clinic
use
treat
pneumonia
ali
caus
viral
infect
yokoyama
et
al
howev
use
limit
poor
pharmacokinet
potenti
risk
organ
toxic
irrevers
inhibit
hne
coval
bind
huang
et
al
ohbayashi
steven
et
al
research
synthet
hne
inhibitor
focus
nitrogencontain
heterocycl
compound
among
superior
hne
select
ic
valu
nm
steven
et
al
compound
bay
seri
also
inhibit
hne
activ
ic
valu
hne
inhibitori
hnei
effect
picomolar
level
structur
modif
also
effect
ali
model
rodent
von
nussbaum
et
al
moreov
natur
terpenoid
report
possess
hnei
effect
lee
et
al
anoth
studi
found
pentacycl
triterpenoid
pt
protect
inflammationinduc
lung
injuri
revers
competit
inhibit
hne
activ
among
pt
ursol
acid
ua
exhibit
highest
inhibitori
potenc
ic
feng
et
al
howev
limit
solubl
poor
bioavail
hinder
practic
use
clinic
drug
liu
sever
strategi
propos
overcom
limit
use
suitabl
drug
deliveri
system
de
oliveira
eloy
et
al
yang
et
al
zhang
et
al
evid
exist
crude
plant
extract
often
greater
vitro
vivo
activ
isol
constitu
equival
dosag
rasoanaivo
et
al
want
determin
whether
ua
plant
extract
would
better
hnei
effect
purifi
ua
therefor
chose
eriobotrya
japonica
loquat
leav
ll
object
materi
china
japan
ll
long
use
herbal
medicin
treat
chronic
bronchiti
cough
cha
et
al
studi
indic
mani
healthrel
benefit
ll
includ
antioxid
antiinflammatori
properti
liu
et
al
maher
et
al
ll
also
known
abund
pt
includ
ua
therefor
studi
elucid
hnei
effect
triterpenoid
composit
loquat
leav
tcll
compar
purifi
ua
vitro
vivo
hne
ec
purul
human
sputum
obtain
innov
research
compani
novi
mi
usa
hne
substrat
meosucalaalaprovalpna
soybean
trypsin
inhibitor
lp
rhodamin
verapamil
dimethyl
sulfoxid
dmso
also
obtain
sigma
st
loui
mo
usa
use
without
purif
sivelestat
sodium
tetrahydr
euscaph
acid
maslin
acid
corosol
acid
oleanol
acid
ua
purchas
dalian
meilun
biotech
co
ltd
dalian
china
dexamethason
sodium
phosphat
inject
purchas
maanshan
fengyuan
pharmaceut
co
ltd
maanshan
anhui
china
chemic
solvent
highperform
liquid
chromatographi
hplc
lcm
hplc
grade
wherea
other
use
studi
analyt
grade
ll
obtain
guangdong
provinc
china
extract
three
time
use
ethanol
time
h
ethanol
remov
reduc
pressur
extract
centrifug
rpm
min
supernat
discard
residu
ad
sodium
hydroxid
residu
gg
dissolv
ethanol
water
solut
residu
lg
mixtur
heat
min
centrifug
rpm
min
hydrochlor
acid
ad
supernat
adjust
ph
solut
centrifug
repeat
obtain
residu
constitut
final
tcll
tcll
fingerprint
establish
hplc
agil
technolog
santa
clara
ca
usa
analyt
column
use
agil
zorbax
sbc
column
mm
mm
mobil
phase
compris
methanol
acetonitril
ammonium
acet
water
solut
flow
rate
mlmin
compound
monitor
nm
kept
column
temperatur
tcll
sampl
dissolv
methanol
mgml
compound
tcll
identifi
compar
retent
time
ms
ion
purchas
standard
compound
report
literatur
uhplclcq
fleet
ion
trap
ms
system
shimadzu
kyoto
japan
uhplc
thermo
fisher
scientif
waltham
usa
ms
chromatograph
separ
perform
use
method
use
establish
tcll
fingerprint
sampl
solut
detect
ms
esi
sourc
neg
mode
oper
paramet
esim
follow
spray
voltag
kv
vapor
temperatur
sheath
aux
ga
pressur
arbitrari
unit
respect
capillari
voltag
v
collis
energi
ev
use
ms
fragment
tcll
sampl
prepar
dissolv
appropri
amount
methanol
produc
final
concentr
mgml
solut
analyz
hplc
use
method
use
establish
tcll
fingerprint
follow
tcll
compound
identif
euscaph
acid
maslin
acid
corosol
acid
oleanol
acid
ua
use
extern
standard
calcul
total
triterpenoid
content
tcll
serial
standard
solut
concentr
mgml
inject
hplc
plot
standard
curv
hnei
activ
bioassay
perform
describ
feng
et
al
use
posit
control
differ
concentr
drug
dissolv
dmso
ad
substrat
solut
mm
meosucalaalaprovalpna
mm
trishcl
buffer
ph
vortex
u
hne
enzym
ad
mixtur
incub
h
protect
light
soybean
trypsin
inhibitor
mgml
ad
solut
ice
stop
interact
sampl
place
plate
auxiliari
hole
per
sampl
measur
nm
use
automat
micropl
reader
biotek
synergi
ht
winooski
vt
usa
ic
valu
calcul
nonlinear
fit
use
graphpad
prism
softwar
male
balbc
mice
weight
g
obtain
shanghai
laboratori
anim
co
ltd
shanghai
china
mice
maintain
lightdark
cycl
control
temperatur
rel
humid
food
water
provid
ad
libitum
treatment
conduct
accord
ethic
guidelin
care
laboratori
anim
approv
ethic
committe
shanghai
univers
tradit
chines
medicin
fifti
mice
randomli
divid
five
group
control
lp
dexamethason
dex
mgkg
ua
mgkg
tcll
mgkg
total
mgkg
tcll
contain
mgkg
total
triterpenoid
equival
amount
ua
ua
group
drug
intragastr
administ
mice
daili
consecut
day
dmso
doubledistil
water
control
lp
group
one
hour
last
drug
administr
control
mice
receiv
salin
other
intraperiton
given
mgkg
lp
induc
acut
lung
inflamm
six
hour
lp
treatment
mice
sacrif
lung
tissu
excis
blood
sampl
balf
collect
analysi
anesthet
heart
lung
mice
surgic
expos
blood
sampl
collect
heart
lung
lavag
three
time
tracheal
cannula
use
ml
cold
salin
obtain
balf
balf
blood
sampl
centrifug
min
rpm
min
respect
supernat
store
analysi
inflammatori
cytokin
concentr
serum
balf
balf
cell
pellet
resuspend
measur
inflammatori
cell
leukocyt
lymphocyt
count
blood
sampl
balf
measur
use
autom
hematolog
analyz
xs
sysmex
shanghai
ltd
shanghai
china
concentr
serum
balf
determin
use
commerci
avail
enzymelink
immunosorb
assay
elisa
kit
mous
elisa
readysetgo
ebiosci
san
diego
ca
usa
spectrophotometr
read
perform
use
automat
micropl
reader
biotek
synergi
ht
winooski
vt
usa
experi
perform
accord
manufactur
instruct
left
lung
lobe
harvest
fix
paraformaldehyd
week
embed
paraffin
stain
use
hematoxylin
eosin
h
e
pulmonari
patholog
chang
observ
microscop
score
system
use
evalu
lung
injuri
includ
pulmonari
atelectasi
interstiti
edema
alveolar
hemorrhag
inflammatori
cell
infiltr
lung
section
score
accord
follow
criteria
injuri
slight
injuri
moder
injuri
sever
injuri
sever
injuri
almost
cell
obtain
american
type
cultur
collect
manassa
va
usa
grown
atmospher
co
air
cultiv
steril
dulbecco
modifi
eagl
medium
mediatech
inc
manassa
va
usa
supplement
heatinactiv
fetal
bovin
serum
biolog
industri
inc
cromwel
ct
usa
cultur
medium
chang
everi
h
cell
grew
confluenc
uptak
experi
perform
describ
song
et
al
cell
seed
plate
treat
use
ua
tcll
contain
ua
drug
dissolv
dmso
dilut
use
hank
buffer
salt
solut
hbss
beyotim
institut
biotechnolog
shanghai
china
two
hour
later
cell
wash
use
phosphat
buffer
salin
hbss
solut
triton
dilut
hbss
ad
mixtur
sonic
min
centrifug
rpm
min
bicinchonin
acid
bca
protein
content
pellet
measur
use
bca
protein
assay
kit
beyotim
institut
biotechnolog
shanghai
china
supernat
ad
acetonitril
use
determin
ua
concentr
cell
vortex
min
mixtur
centrifug
g
min
supernat
analyz
lcm
ua
concentr
cell
determin
lcm
ultim
uhplctsq
tripl
quadrupol
ms
system
thermo
fisher
scientif
waltham
usa
equip
zorbax
eclips
polyaromat
hydrocarbon
column
pack
particl
mm
l
id
agil
technolog
santa
clara
ca
usa
mobil
phase
compris
acetonitril
ultrapur
water
vv
flow
rate
mlmin
sampl
inject
volum
column
temperatur
kept
cell
extract
detect
ms
esi
interfac
neg
selectedion
monitor
mode
monitor
mh
ion
mz
ua
oper
paramet
esim
follow
spray
voltag
kv
vapor
temperatur
sheath
aux
ga
pressur
arbitrari
unit
respect
capillari
temperatur
data
express
mean
standard
deviat
data
hnei
effect
uptak
ua
cell
analyz
use
independ
sampl
ttest
data
analyz
oneway
analysi
varianc
follow
least
signific
differ
post
hoc
test
analys
perform
use
spss
tcll
fingerprint
obtain
accord
procedur
describ
method
section
eight
peak
detect
tcll
fingerprint
fig
peak
identifi
compar
retent
time
ion
inform
standard
liquid
chromatographymass
spectrometri
lcm
tabl
therefor
confirm
peak
euscaph
acid
peak
maslin
acid
corosol
acid
oleanol
acid
ua
respect
deproton
ion
ms
fragment
ion
peak
tabl
consist
report
compound
acid
deproton
ion
ms
fragment
ion
moreov
compound
acid
isol
ll
fig
tan
et
al
deproton
ion
ms
fragment
ion
peak
basic
cao
et
al
tan
et
al
wang
et
al
wu
et
al
peak
presum
ci
tran
isom
respect
acid
isol
ll
tan
et
al
mixtur
peak
examin
nuclear
magnet
reson
obtain
h
nmr
spectrum
area
peak
significantli
greater
peak
h
nmr
spectrum
indic
presenc
ci
tran
coumaroyl
moieti
j
hz
j
hz
tran
isom
j
hz
ci
isom
taniguchi
et
al
peak
area
scale
peak
area
indic
content
transstructur
compound
mixtur
approxim
time
cisstructur
one
peak
confirm
acid
peak
confirm
acid
content
euscaph
acid
maslin
acid
corosol
acid
oleanol
acid
ua
calcul
respect
accord
correspond
standard
curv
content
acid
acid
acid
calcul
use
ua
standard
curv
respect
calcul
total
pt
content
tcll
hnei
effect
tcll
examin
use
hne
vitro
activ
assay
posit
control
ic
valu
nm
ua
tcll
could
inhibit
hne
activ
maximum
inhibit
approxim
assay
ic
valu
tcll
significantli
lower
ua
p
tabl
fig
tcll
thu
superior
hnei
effect
vitro
ua
evalu
effect
tcll
ali
leukocyt
lymphocyt
blood
leukocyt
balf
count
dose
tcll
ua
mgkg
mgkg
respect
dose
total
pt
tcll
equal
ua
ua
group
six
hour
lp
inject
leukocyt
blood
balf
lymphocyt
blood
significantli
decreas
p
wherea
tcll
increas
leukocyt
p
lymphocyt
p
blood
leukocyt
p
balf
howev
leukocyt
lymphocyt
blood
balf
ua
group
mice
significantli
differ
lp
group
p
fig
lp
inject
level
serum
balf
significantli
increas
p
tcll
reduc
level
serum
balf
p
fig
howev
serum
level
ua
group
significantli
higher
tcll
group
p
fig
indic
effect
ua
decreas
serum
weaker
tcll
histolog
chang
lung
tissu
observ
light
microscopi
examin
therapeut
effect
tcll
lung
injuri
evid
histolog
alter
observ
control
group
lp
administr
caus
obviou
patholog
chang
alveolar
wall
thicken
collaps
inflammatori
cell
infiltr
congest
edema
tcll
treatment
significantli
attenu
histolog
chang
induc
lp
wherea
ua
treatment
significantli
reduc
destruct
effect
lung
injuri
fig
lung
injuri
score
present
fig
result
indic
tcll
could
reduc
degre
patholog
inflamm
lung
tissu
ali
effect
superior
ua
ua
uptak
cell
ua
tcll
group
examin
lcm
ua
dose
equal
group
howev
ua
uptak
tcll
group
significantli
greater
ua
group
p
fig
result
indic
ua
uptak
cell
could
promot
mixtur
state
involv
variou
triterpenoid
ll
use
sinc
ancient
time
treat
inflammatori
diseas
cough
chronic
bronchiti
asthma
extract
ll
reportedli
abund
triterpenoid
possess
antiinflammatori
effect
suppress
nuclear
express
activ
cha
et
al
kim
shin
kwon
et
al
lee
et
al
uto
et
al
mitogenactiv
protein
kinas
signal
pathway
huang
et
al
kim
shin
uto
et
al
fig
triterpenoid
composit
loquat
leav
tcll
fingerprint
obtain
highperform
liquid
chromatographi
hplc
comparison
retent
time
ms
ion
peak
peak
standard
neg
fullscan
mode
zhang
et
al
journal
ethnopharmacolog
studi
antipulmonaryinflamm
effect
extract
prove
relat
hnei
effect
use
rel
simpl
method
obtain
tcll
extract
ll
abund
pt
tcll
contain
eight
main
pt
ll
includ
ua
result
indic
tcll
signific
hnei
effect
vitro
therapeut
effect
lpsinduc
inflamm
mous
model
specif
tcll
significantli
increas
leukocyt
count
reduc
inflammatori
cytokin
blood
balf
histolog
chang
induc
lp
also
significantli
attenu
tcll
furthermor
data
show
tcll
lower
ic
valu
hnei
effect
vitro
effect
treat
ali
vivo
ua
twofold
explan
may
explain
tcll
perform
superiorli
vitro
certain
pt
constitu
tcll
might
stronger
hnei
effect
ua
wherea
vivo
pharmacodynam
synergist
effect
pharmacokinet
interact
pt
tcll
might
occur
pglycoprotein
pgp
one
major
human
transmembran
transport
zhou
decreas
oral
bioavail
mani
drug
substrat
efflux
mechan
eckford
sharom
studi
report
pt
like
substrat
pgp
solid
dispers
total
pt
cao
et
al
tan
et
al
wang
et
al
wu
et
al
fig
structur
eight
compound
tcll
ll
contain
euscaph
acid
maslin
acid
corosol
acid
oleanol
acid
ua
coadminist
pgp
inhibitor
verapamil
rat
model
rel
bioavail
pt
increas
cai
studi
ua
uptak
tcll
perform
cell
result
indic
ua
uptak
cell
tcll
higher
ua
alon
result
demonstr
pt
tcll
like
pgp
substrat
compet
bind
pgp
therebi
increas
ua
uptak
cell
ua
one
major
activ
compon
ll
along
hnei
antiinflammatori
activ
ua
mani
pharmacolog
properti
wozniak
et
al
includ
anticanc
antioxid
antibacteri
activ
studi
demonstr
tcll
enhanc
hnei
effect
well
therapeut
effect
lpsinduc
inflamm
tcll
simpl
inexpens
prepar
ll
extract
could
replac
ua
pharmacolog
applic
credit
authorship
contribut
statement
effect
tcll
inflammatori
cell
blood
bronchoalveolar
lavag
fluid
balf
lipopolysaccharid
lp
induc
acut
lung
injuri
ali
mice
total
leukocyt
blood
b
lymphocyt
blood
c
total
leukocyt
balf
data
present
mean
sd
n
p
compar
control
group
p
p
compar
lp
group
c
level
balf
data
present
mean
sd
n
p
compar
control
group
p
p
compar
lp
group
p
compar
ua
group
research
support
nation
natur
scienc
foundat
china
excel
academ
leader
program
shanghai
shanghai
scienc
technolog
innov
action
plan
program
shanghai
eresearch
institut
bioactiv
constitu
tradit
chines
medicin
author
declar
conflict
interest
supplementari
data
associ
articl
found
fig
effect
tcll
lpsmediat
histolog
chang
lung
tissu
hematoxylin
eosin
h
e
stain
control
group
b
lp
group
c
dexamethason
dex
mgkg
group
ua
mgkg
group
e
tcll
mgkg
group
f
lung
injuri
score
data
present
mean
sd
n
p
compar
control
group
p
p
compar
lp
group
